Beijing Chao Yang Hospital
Clinical trials sponsored by Beijing Chao Yang Hospital, explained in plain language.
-
Could a probiotic help tame New-Onset diabetes?
Disease control Not yet recruitingThis study looks at whether a probiotic called Lactobacillus paracasei LC19 can help control blood sugar in people recently diagnosed with type 2 diabetes. About 70 adults who have not taken diabetes medication will take the probiotic daily for 12 weeks. Researchers will measure …
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
Can pressurized oxygen boost brain healing after stroke?
Disease control Not yet recruitingThis study tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen) can improve recovery in people who had a stroke and received a procedure to reopen a blocked artery. About 424 adults aged 35-75 will receive 10 one-hour sessions over 5 weeks. Researchers…
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New ventilation method aims to shield heart in severe pneumonia patients
Disease control Not yet recruitingThis study tests whether a special breathing machine strategy, guided by lung pressure measurements, can better protect the right side of the heart in patients with severe pneumonia and lung injury (ARDS). About 180 adults on breathing machines will be enrolled. The goal is to se…
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Could earlier aspirin after stroke save more brain function?
Disease control Not yet recruitingThis study looks at whether giving a low-dose aspirin just 2 hours after clot-busting treatment for stroke is safer and more effective than waiting the usual 24 hours. About 210 adults aged 18-65 with acute ischemic stroke will be randomly assigned to one of two timing schedules.…
Phase: PHASE4 • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Gut check: Semaglutide's hidden effect on obesity bacteria
Knowledge-focused Not yet recruitingThis study looks at how the weight-loss drug semaglutide changes the gut bacteria in 40 adults with obesity. Participants will take semaglutide for 12 weeks, and researchers will analyze their stool samples to see how the bacteria composition shifts. The goal is to understand the…
Sponsor: Beijing Chao Yang Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC